Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of Diabetes

(MedPage Today) -- CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with or without type 2 diabetes, a pair of phase IIIa trials found.
In REDEFINE 1, which included 3,417...